MEDICAL INSTRUMENTS

Thermo Fisher to acquire Brammer Bio in $1.7 bln deal

Brammer Bio, a viral vector manufacturer for gene and cell therapies, is expected to post $250 million in revenue for 2019, Thermo Fisher said in a statement.